WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it will webcast its First Annual Investor Event being held Tuesday, October 21, 2008 at 8:30 a.m. ET in New York City. The event will feature presentations by the Company’s senior management team:
